An Open-Label, Two-Arm (DefenCath® vs. Institutional Standard of Care) Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to Less Than 18 Years of Age With Kidney Failure Receiving Hemodialysis Via a Central Venous Catheter
Latest Information Update: 06 Nov 2025
At a glance
- Drugs Citrate/heparin/taurolidine (Primary)
- Indications Catheter infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors CorMedix
Most Recent Events
- 11 Jul 2025 Status changed from not yet recruiting to recruiting.
- 22 May 2025 Planned initiation date changed from 1 Apr 2025 to 1 May 2025.
- 12 Feb 2025 Planned initiation date changed from 1 Dec 2024 to 1 Apr 2025.